ABSTRACTS SEARCH

Search results

  • Systematic review and meta-analysis using SyRF- a tool to accelerate drug development
    G. L. Currie, J. Liao, E. S. Sena, C. T. Sena, A. Bannach-Brown, K. Hair, S. K. McCann, Q. Wang, M. R. Macleod. CCBS, University of Edinburgh, Edinburgh, United Kingdom,
  • The anti-cancer and anti-inflammatory effects of curcumin in multiple human cancer cells
    M. A. Baghdadi1, H. Almosa2,3, Z. Almalki2,3, M. Alqriqri4, I. Denetiu4, M. H. Ucisik5,6, S. Damiati2. 1Research Centre, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia, 2Biochemistry, Faculty of Science, King Abdulaziz University (KAU), Jeddah, Saudi Arabia, 3Jamjoom Pharmaceutical, Jeddah, Saudi Arabia, 4King Fahed Medical Research Center, Jeddah, Saudi Arabia, 5Biomedical Engineering, School of Engineering and Natural Sciences, Istanbul Medipol University, Istanbul, Turkey, 6Medipol Regenerative and Restorative Medicine Research Center (REMER), Istanbul, Turkey,
  • The IUPHAR/BPS Guide to PHARMACOLOGY database (GtoPdb) in 2018: new features and updates
    A. J. Pawson1, J. L. Sharman1, J. Armstrong1, E. Faccenda1, S. D. Harding1, C. Southan1, S. P. Alexander2, A. P. Davenport3, M. Spedding4, J. A. Davies1. 1Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom, 2School of Life Sciences, University of Nottingham, Nottingham, United Kingdom, 3Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, United Kingdom, 4Spedding Research Solutions SAS, Le V‚sinet, France,
  • The IUPHAR Guide to IMMUNOPHARMACOLOGY portal
    S. D. Harding1, E. Faccenda1, C. Southan1, J. L. Sharman1, A. J. Pawson1, A. J. Gray2, S. Ireland1, S. P. Alexander3, S. Anderton4, C. Bryant5, A. P. Davenport6, C. Doerig7, D. Fabbro8, F. Levi-Schaffer9, M. Spedding10, J. A. Davies1. 1Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom, 2School of Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh, United Kingdom, 3School of Life Sciences, University of Nottingham, Nottingham, United Kingdom, 4MRC Centre for inflammation Research, University of Edinburgh, Edinburgh, United Kingdom, 5Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom, 6Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, United Kingdom, 7Department of Microbiology, Monash University, Clayton, Australia, 8PIQUR Therapeutics, Basel, Switzerland, 9Pharmacology and Experimental Therapeutics Unit, Hebrew University of Jerusalem, Jerusalem, Israel, 10Spedding Research Solutions SAS, Le V‚sinet, France,
  • Use of Au-functionalized devices for the specific activation of a bioorthogonal Belinostat prodrug
    B. Rubio-Ruiz, A. P‚rez?L˘pez, A. Unciti-Broceta. Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, United Kingdom,
  • 1 |
  • 2